Mark Fung, M.D., Ph.D.

Mark Fung, M.D., Ph.D.

Professor, Department of Pathology & Laboratory Medicine
Director of HLA & Stem Cell Processing Labs, Department of Pathology & Laboratory Medicine
Vice Chair, Population Health, Department of Pathology & Laboratory Medicine
Vice Chair for Research, Department of Pathology & Laboratory Medicine

Contact Information
E-mail: Mark.Fung@uvm.edu
Office Location:
EP1-103

Expertise

Transfusion medicine and HLA

Research Interests

Transfusion safety, regional and national transfusion practices, blood donor motivation, transfusion outcomes, HLA platelet compatibility

Postdoctoral Training

2014 Course in Meta-Leadership in Healthcare – 16 credit hours; Harvard School of Public Health,
         Boston, MA, U.S.A.
2012 Course in Leadership Development for Physicians in Academic Health Centers (Institutional
         Policy and Strategy, Operations Management, Financial Analysis and Control, Organizational
         Issues, Conflict Resolution and Negotiation, Clinical Performance Management) – 55 credit
         hours; Harvard School of Public Health, Boston, MA, U.S.A.
2009-2011 Core and Advanced Business Education Program (Organizational Behavior, Finance,
                  Marketing, Operations, Strategy, Negotiations, Project Management) – 40+ credit hours,
                  University of Vermont Center for Health Care Management, Burlington, VT, U.S.A.
2005-2007 Fellow, Program for Research in Medical Outcomes (PRIMO Fellow), Department of
                  General Internal Medicine, University of Vermont, Burlington, VT, U.S.A.
2002-2003 Clinical Fellow, Transfusion Medicine and Blood Banking, University of Pittsburgh
                  School of Medicine and Institute for Transfusion Medicine, Pittsburgh, PA, U.S.A.
2001-2004 Resident in Pathology and Laboratory Medicine (AP/CP), University of Pittsburgh
                  School of Medicine, Pittsburgh, PA, U.S.A.
1999-2001 Resident in Pathology and Laboratory Medicine (AP/CP), Washington University School
                  of Medicine, Saint Louis, MO, U.S.A.

Education

1999 MD, University of Alabama School of Medicine, Birmingham, AL, (Medical Scientist Training Program)

1997 PhD, Univ. of Alabama at Birmingham, AL (Molecular and Cellular Pathology)

1991 MS, Univ. of Illinois at Urbana-Champaign, Urbana, IL (Microbiology)

1989 BA, Wesleyan University, Middletown, CT (Biology)

Academic Appointments

2021-present Vice Chair for Research, Department of Pathology & laboratory Medicine, Larner College of Medicine, University of Vermont
2015-present Professor, Department of Pathology and Laboratory Medicine, University of Vermont, College of Medicine, Burlington, VT, U.S.A.
2013-present Associate Professor (secondary appointment) and Medical Laboratory Science Medical Director, Department of Medical Laboratory and Radiation Sciences,University of Vermont, College of Nursing and Health Sciences, Burlington, VT, U.S.A.
2010-2015 Associate Professor, Department of Pathology and Laboratory Medicine, University of Vermont, College of Medicine, Burlington, VT, U.S.A.
2004-2010 Assistant Professor, Department of Pathology and Laboratory Medicine, University of Vermont, College of Medicine, Burlington, VT, U.S.A.

Awards and Honors

2015 Master Teacher, University of Vermont College of Medicine Teaching Academy
2015 Nominee, Silver Stethoscope medical student teaching award, UVM
2013 Being One Award, University of Vermont Medical Center
2012 Faces of Fletcher Allen, University of Vermont Medical Center
2009 Good Catch Award, University of Vermont Medical Center
2003 Foundation Scholar, College of American Pathologists (CAP)

Publications

“Assessment of Flow Cytometry and Kleihauer-Betke Method When Calculating Fetomaternal Hemorrhage and Rh Immunoglobulin Dose.”
Gereg C, Fung MK.
Arch Pathol Lab Med. 2022 Mar 1;146(3):271. doi: 10.5858/arpa.2021-0432-LE.PMID: 35192697 No abstract available.

“Preparation of clinical-grade WBCs using leukocyte reduction filters.”
Shukla GS, Pero SC, Mei L, Hitchcox S, Fung M, Sprague J, Krag DN.
J Immunol Methods. 2021 Sep 28:113157. doi: 10.1016/j.jim.2021.113157. Online ahead of  print. PMID: 34597620

“The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.”
Cho JH, Rajbhandary S, van Buren NL, Fung MK, Al-Ghafry M, Fridey JL, Dy BA, Ziman A, Schreiber GB, Gammon RR, Reik R, Stubbs JR, van Buskirk CM, Kamel H, Townsend MJ, Zeller MP, Gottschall JL.
Transfusion. 2021 Jul 6. doi: 10.1111/trf.16572. Online ahead of print. PMID: 34227689

“All Hands-On Deck and All Decks on Hand: Surmounting Supply Chain Limitations During the COVID-19 Pandemic.”
Warrington JS, Crothers JW, Goodwin A, Coulombe L, Hong T, Bryan L, Wojewoda C, Fung M, Warrington G, Clark V, Risley L, Lewis M.
Acad Pathol. 2021 May 11;8:23742895211011928. doi: 10.1177/23742895211011928. eCollection 2021 Jan-Dec. PMID: 34027053 Free PMC article.

“A Primer on CAR-T Therapy: What Does It Mean for Pathologists?: A Summary Guidance From the College of American Pathologists CAR-T Workgroup.”

Cushman-Vokoun AM, Voelkerding KV, Fung MK, Nowak JA, Thorson JA, Duncan HL, Kalicanin T, Anderson MW, Yohe S.

Arch Pathol Lab Med. 2020 Nov 25. doi: 10.5858/arpa.2019-0632-CP. Online ahead of print. PMID: 33237994

“Safety incident reports associated with blood transfusions.”
Vossoughi S, Perez G, Whitaker BI, Fung MK, Rajbhandary S, Crews N, Stotler B.
Transfusion. 2019 Sep;59(9):2827-2832. doi: 10.1111/trf.15429. Epub 2019 Jun 29.

“Electronic patient identification for sample labeling reduces wrong blood in tube errors.”
Kaufman RM, Dinh A, Cohn CS, Fung MK, Gorlin J, Melanson S, Murphy MF, Ziman A, Elahie AL, Chasse D, Degree L, Dunbar NM, Dzik WH, Flanagan P, Gabert K, Ipe TS, Jackson B, Lane D, Raspollini E, Ray C, Sharon Y, Ellis M, Selleng K, Staves J, Yu P, Zeller M, Yazer M, BEST Collaborative.
Transfusion. 2019 Mar;59(3):972-980. doi: 10.1111/trf.15102. Epub 2018 Dec 14. PMID: 30549289

“Improving the performance of virtual crossmatch results by correlating with nationally-performed physical crossmatches: Obtaining additional value from proficiency testing activities.”
Wrenn SM, Marroquin CE, Hain DS, Harm SK, Pineda JA, Hammond PB, Shah DH, Hillyard SE, Fung MK.
Hum Immunol. 2018 Aug;79(8):602-609. doi: 10.1016/j.humimm.2018.05.009. Epub 2018 Jun 1. PMID: 29864460

“Analysis of pediatric adverse reactions to transfusions.”
Vossoughi S, Perez G, Whitaker BI, Fung MK, Stotler B.
Transfusion. 2018 Jan;58(1):60-69. doi: 10.1111/trf.14359. Epub 2017 Sep 25. PMID: 28948619

“Prothrombin complex concentrate for emergent reversal of warfarin: an international survey of hospital protocols.”
Gorlin J, Kinney S, Fung MK, Tinmouth A; BEST Collaborative.
Vox Sang. 2017 Aug;112(6):595-597. doi: 10.1111/vox.12539. Epub 2017 Jun 21. PMID: 28635130

For a complete list of Dr. Fung's publications, please visit PubMed.